SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-022110
Filing Date
2022-04-28
Accepted
2022-04-28 07:01:39
Documents
13
Period of Report
2022-04-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea158986-8k_inmunebio.htm   iXBRL 8-K 25037
2 PRESS RELEASE, DATED APRIL 28, 2022 ea158986ex99-1_inmunebio.htm EX-99.1 9757
  Complete submission text file 0001213900-22-022110.txt   213510

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE inmb-20220428.xsd EX-101.SCH 3036
4 XBRL LABEL FILE inmb-20220428_lab.xml EX-101.LAB 34476
5 XBRL PRESENTATION FILE inmb-20220428_pre.xml EX-101.PRE 22597
7 EXTRACTED XBRL INSTANCE DOCUMENT ea158986-8k_inmunebio_htm.xml XML 3711
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 22862125
SIC: 2836 Biological Products, (No Diagnostic Substances)